2025-12-13 - Analysis Report
Here's a comprehensive analysis of Albemarle Corp. (ALB) based on the provided data.

**1. Performance vs. S&P 500 (VOO)**

*   **Company Overview:** Albemarle Corp. is a specialty chemicals company and a leading producer of lithium, bromine, and catalysts.
*   **Cumulative Return:**
    *   ALB: 28.35%
    *   VOO: 102.37%
*   **Divergence:** -78.7 (Relative Divergence: 13.4). This means ALB has significantly underperformed the S&P 500. The relative divergence indicates that the current difference in returns is near the lower end of its historical range.

*   **Alpha, Beta Analysis:**

| Year       | CAGR      | MDD     | Alpha    | Beta   | Cap(B) |
|------------|-----------|---------|----------|--------|--------|
| 2015-2017  | 85.0%     | 68.0%   | 56.0%    | 0.1    | 15.0   |
| 2016-2018  | 9.0%      | 68.0%   | -6.0%    | 0.0    | 9.0    |
| 2017-2019  | -44.0%    | 73.9%   | -66.0%   | 0.1    | 8.6    |
| 2018-2020  | 44.0%     | 79.4%   | 20.0%    | 0.2    | 17.3   |
| 2019-2021  | 149.0%    | 79.4%   | 103.0%   | -0.1   | 27.4   |
| 2020-2022  | 148.0%    | 79.9%   | 149.0%   | 0.5    | 25.4   |
| 2021-2023  | -26.0%    | 81.9%   | -27.0%   | 0.5    | 16.9   |
| 2022-2024  | -152.0%   | 81.9%   | -172.0%  | 0.3    | 10.1   |
| 2023-2025  | -193.0%   | 81.9%   | -260.0%  | -1.0   | 15.6   |

*   **Analysis:**
    *   ALB has shown periods of very high growth (CAGR), particularly from 2019-2022.
    *   Recent years (2022-2025) show significant negative CAGR, reflecting a steep decline in performance.
    *   Maximum Drawdown (MDD) is consistently high, indicating substantial price volatility.
    *   Alpha has been strongly positive during periods of high growth, indicating outperformance relative to its risk (Beta). However, recent years show extremely negative Alpha, implying significant underperformance.
    *   Beta values are generally low, meaning the stock is not highly correlated with the overall market. Recent beta going negative (-1.0) would indicate an inverse correlation with the market.

**2. Recent Stock Price Fluctuations**

*   **Current Price:** 133.21
*   **Last Market Data:** Price: 132.74, Previous Close: 134.185, Change: -1.08
*   **Moving Averages:**
    *   5-day SMA: 126.81
    *   20-day SMA: 122.65
    *   60-day SMA: 102.00

*   **Analysis:** The stock price is above all three moving averages, which is generally considered bullish. The 5-day SMA is above the 20-day SMA, which is also a positive sign. The small negative change in the last market data suggests some recent selling pressure.

**3. Market Risk Indicators and Expected Return**

*   **Market Risk Indicator (MRI):** 0.8 (Medium Investment)
*   **RSI:** 57.59 (Neutral - neither overbought nor oversold)
*   **PPO:** -0.32 (Slightly Bearish)
*   **Hybrid Signal:** Buy 100% of cash (8 shares - Very Safe - MRI:0.90), Monthly invest 0.8% of total investment ($1,000.00) (Cash Ratio: 0% on 2025-12-01)
*   **Recent Divergence Change:** -0.1 (Short-term decline)
*   **Expected Return:** 140.2% (Long-term, >2 years)

*   **Analysis:**
    *   The MRI suggests a medium level of investment risk.
    *   The RSI is neutral, indicating no immediate overbought or oversold conditions.
    *   The negative PPO suggests a slight bearish momentum.
    *   Despite recent declines, the expected return is very high, suggesting potential for significant long-term growth. This should be viewed with caution, given the recent underperformance. The Hybrid Signal suggests buying, but the MRI is only moderate. The recent divergence change indicates that the short term has some downward momentum.

**4. Recent News & Significant Events**

*   **[2025-12-11] Lithium Deficit Could Boost Albemarle (ALB) Stock:** Positive news, suggesting potential future growth.
*   **[2025-11-27] LAC vs. ALB: Which Lithium Stock Has More Upside Potential Now?:** Comparative analysis, indicating ALB is being compared to its competitors.
*   **[2025-11-17] Albemarle Leads S&P 500 As Lithium Becomes An AI Play:** Positive headline, linking lithium demand to the growing AI industry.
*   **[2025-12-05] Stocks making the biggest moves midday...Albemarle and more:** Suggests ALB has had notable intraday price movements.
*   **[2025-12-05] Albemarle Stock Jump Looks Great, But How Secure Is That Gain?:** Cautious analysis, questioning the sustainability of recent gains.
*   **[2025-12-08] Albemarle (ALB) Just Overtook the 20-Day Moving Average:** Technical analysis, indicating a potentially bullish signal.

*   **Analysis:** The news is mixed. There are positive headlines suggesting future growth due to lithium demand, but also cautious articles questioning the sustainability of recent price increases.

**4-2. Analyst Opinions**

*   **Consensus:** Buy (Mean: 2.5 - Hold)
*   **Target Price:** Average: $112.75, High: $200, Low: $58
*   **Recent Rating Changes:**  No changes were provided in the prompt's data.

*   **Analysis:**  The analyst consensus is "Hold", despite the classification given of "Buy", the Mean suggests the consensus is not an overwhelming buy recommendation. The average target price is below the current price, suggesting potential downside. The wide range of target prices indicates uncertainty among analysts.

**5. Recent Earnings Analysis**

| 날짜         | EPS   | 매출      |
|-------------|-------|-----------|
| 2025-11-05  | -1.72 | 1.31 B$   |
| 2025-08-04  | -0.16 | 1.33 B$   |
| 2025-04-30  | 0     | 1.08 B$   |
| 2024-11-06  | -9.45 | 1.35 B$   |
| 2025-11-05  | -9.45 | 1.35 B$   |

*   **Analysis:**
    *   Recent EPS figures are negative. There was significant loss, according to the 2024-11-06 result. There was significant loss again, according to the 2025-11-05 result.
    *   Revenue has fluctuated.
    *   Overall, the earnings data is concerning, showing a lack of profitability.

**6. Financial Information**

| Quarter      | Revenue   | Profit Margin |
|--------------|-----------|---------------|
| 2025-09-30   | $1.31B    | 8.99%         |
| 2025-06-30   | $1.33B    | 14.80%        |
| 2025-03-31   | $1.08B    | 14.51%        |
| 2024-12-31   | $1.23B    | 11.22%        |
| 2024-09-30   | $1.35B    | -7.68%        |

| Quarter      | Equity    | ROE      |
|--------------|-----------|----------|
| 2025-09-30   | $10.00B   | -1.61%   |
| 2025-06-30   | $10.24B   | 0.22%    |
| 2025-03-31   | $10.03B   | 0.41%    |
| 2024-12-31   | $9.96B    | 0.76%    |
| 2024-09-30   | $10.24B   | -10.44%  |

*   **Analysis:**
    *   Revenue has been relatively stable over the past few quarters, with some fluctuation.
    *   Profit margins have been positive in most recent quarters, but were negative in Q3 2024.
    *   Equity has remained relatively stable.
    *   ROE has been mostly negative.

**7. Comprehensive Analysis**

*   **Underperformance:** Albemarle has significantly underperformed the S&P 500, especially in recent years.
*   **Volatility:** The stock exhibits high volatility, as indicated by the high Maximum Drawdown.
*   **Mixed Signals:** Technical indicators provide mixed signals. The price is above its moving averages, which is bullish, but the PPO is slightly bearish.
*   **News & Analyst Uncertainty:** Recent news is mixed, with some positive catalysts but also cautionary notes. Analyst opinions are mixed, with a "Hold" consensus and a wide range of target prices.
*   **Profitability Concerns:** Recent earnings data and ROE show lack of profitability.
*   **Long-Term Potential vs. Short-Term Risks:** While the expected return is high, suggesting long-term potential, the recent underperformance, negative earnings, and mixed analyst sentiment warrant caution.
* **Overall:** Albemarle presents a high-risk, high-reward scenario. The company operates in a sector with potential for growth (lithium and AI), but faces near-term challenges related to profitability and stock performance. The positive long-term expected return should be considered in light of the recent history of negative returns. Investment decisions should be based on individual risk tolerance and a thorough understanding of the company's financials and market dynamics.


**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.